What is Mineralys Therapeutics, Inc. Common Stock's share price today?
Mineralys Therapeutics, Inc. Common Stock (MLYS) share price today is $20.37 as of October 27, 2026 at 1:22 AM IST. The stock touched a day high of $20.82 and a day low of $20.29.What exchange does Mineralys Therapeutics, Inc. Common Stock stock trade on, and under what ticker symbol?
Mineralys Therapeutics, Inc. Common Stock stock trades on NASDAQ under the ticker symbol MLYS.What is Mineralys Therapeutics, Inc. Common Stock's market capitalization?
Mineralys Therapeutics, Inc. Common Stock's market capitalization is $1.81B as of October 27, 2026 at 1:22 AM IST.What is Mineralys Therapeutics, Inc. Common Stock's price-to-earnings (P/E) ratio?
Mineralys Therapeutics, Inc. Common Stock's price-to-earnings (P/E) ratio is N/A as of October 26, 2026.What is Mineralys Therapeutics, Inc. Common Stock's price-to-book (P/B) ratio?
Mineralys Therapeutics, Inc. Common Stock's price-to-book (P/B) ratio is 10.00 as of October 26, 2026.Can Indian investors buy Mineralys Therapeutics, Inc. Common Stock shares?
Yes, You can buy Mineralys Therapeutics, Inc. Common Stock shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Mineralys Therapeutics, Inc. Common Stock shares from India?
Indian investors can buy Mineralys Therapeutics, Inc. Common Stock shares in three steps: 1. Search Mineralys Therapeutics, Inc. Common Stock on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Mineralys Therapeutics, Inc. Common Stock shares for Indian investors?
Since Mineralys Therapeutics, Inc. Common Stock trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Mineralys Therapeutics, Inc. Common Stock shares via Tickertape?
Indian investors can start investing in Mineralys Therapeutics, Inc. Common Stock (MLYS) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.4908 shares at the current price of $20.37.
$
₹
$20.370.86% (-0.17)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
—
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
10.00
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$-4.3
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
0%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Based on 11 analysts reports
Buy9 analysts
Hold2 analysts
Sell0 analyst
Price Upside
+125.47%
Earnings Growth
-87.03%
Rev. Growth
—
Company Profile
Company Profile
ABBV
P/E Ratio
80.68
80.68
1Y Return
24.94%
24.94%
Buy Reco %
80.00
80.00
AMGN
P/E Ratio
27.28
27.28
1Y Return
51.04%
51.04%
Buy Reco %
35.29
35.29
P/E Ratio
—
—
1Y Return
29.23%
29.23%
Buy Reco %
78.57
78.57
P/E Ratio
29.90
29.90
1Y Return
23.96%
23.96%
Buy Reco %
81.25
81.25
MRNA
P/E Ratio
—
—
1Y Return
662.28%
662.28%
Buy Reco %
21.73
21.73
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
2026
Current$20.55Baseline
Analyst Target - 1 year
Target$46.33+125.47%
All values in $
2026
Current$20.55Baseline
Analyst Target - 1 year
Target$46.33+125.47%
All values in $
Earnings Per Share Forecast
Earnings Per Share Forecast
2025
Current$-2.37Baseline
Forecast for Dec 2026
High$-3.93-65.82%
Average$-4.43-87.03%
Low$-4.63-95.36%
All values in $
2025
Current$-2.37Baseline
Forecast for Dec 2026
High$-3.93-65.82%
Average$-4.43-87.03%
Low$-4.63-95.36%
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -0 | -0 | -0.01 | 0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0 | - |
| Net Income | -31.50 | -41.01 | -56.34 | -48.94 | -42.21 | -43.27 | -36.93 | -32.23 | -39.33 | -241.07 |
| Net Profit Margin | - | - | - | -143958.82% | - | - | - | - | - | - |
Peers
Peers & Comparison
Peers & Comparison
Comparing 2 stocks from
HealthcareBiotechnology
HealthcareBiotechnology
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. Common Stock | - | 10.00 | - |
| AbbVie Inc | 80.68 | 50.45 | 0.53 |
| Amgen Inc | 27.28 | 17.56 | 2.28 |
Price Comparison
Price Comparison
Compare MLYS with any stock or ETFCompare MLYS with any stock or ETF
Comparing from
MLYS
ABBV
AMGN
The 12-month consensus target implies 125.47% growth, versus a trailing 3-year CAGR of 34.69%.